Importance of Follow-Up Cerebrospinal Fluid Analysis in Cryptococcal Meningoencephalitis
Table 1
Patient’s characteristics.
Parameter
All patients
Survivors
Nonsurvivors
Characteristics
Age, years (mean)
44 (±16)
43 (±16)
46 (±17)
Male (no.)
16
11
5
Duration of symptoms to diagnosis, days (mean)
16 (±13)
16 (±16)
16 (±6)
Symptoms on presentation
Headache (no.)
15
12
3
Disturbance of consciousness (no.)
13
9
4
Fever (no.)
10
6
4
Nausea and vomiting (no.)
8
8
0
Focal neurologic deficits (no.)
3
3a
0
Stiff neck (no.)
3
2
1
Seizures (no.)
1
0
1
Complications during hospitalization
Neurologic complications
Progressive consciousness disturbance (no.)
6
0
6
Seizures (no.)
3
1
2
Focal neurologic deficits (no.)
3
1b
2c
Cerebral infarction (no.)
2
0
2
Nonneurologic complications
Electrolyte disturbance (no.)
21
15
6
Elevated transaminases (no.)
17
13
4
Hypercreatinemia (no.)
11
8
3
Allergic reaction (no.)
2
2
0
Focal neurologic deficits: aphasia (3/3) and ataxia (1/3).
bFocal neurologic deficit: abducens nerve palsy (1/1).
cFocal neurologic deficit: abducens nerve palsy (2/2) and facial palsy (1/2).
Age and duration of symptoms to diagnosis are presented by mean value and standard deviation.
